Lam Research: 30% Growth And Expanding Margins Make It A Solid Buy

Lam Research received a Buy rating as its plasma dry etching technology is seen as a key moat in advanced memory manufacturing. The AI infrastructure buildout and hyperscaler CapEx are supporting a memory super cycle, while Q3 revenue rose 24% YoY to $5.84B with ~30% net margins. Customer support revenue hit a record $2B, improving recurring revenue visibility and reinforcing margin stability.

Analysis

LRCX is increasingly less a single-quarter equipment story and more a structural toll collector on the memory upgrade cycle. The key second-order effect is that AI-capex is forcing hyperscalers to optimize not just compute but bytes-per-watt and bytes-per-dollar, which pushes spending into advanced NAND and DRAM nodes where etch intensity rises faster than wafer starts. That should support both mix and pricing power for Lam relative to the broader semi-capex basket, especially versus tools with more exposure to leading-edge logic where spend can be more lumpy.

The market is probably still underestimating the quality of Lam’s earnings stream. A larger installed base and a record support business imply the next leg of growth can be more resilient than the headline wafer-fab equipment cycle suggests, because service revenue lags tool demand and cushions any eventual moderation in orders. In a memory upcycle, that mix shift matters: if customer spending pauses, the service attach and process complexity can keep margins from mean-reverting as quickly as many expect.

The main risk is not near-term demand but timing: memory cycles can stay irrational longer than positioning, then correct sharply when inventories normalize or hyperscaler digestion begins. The catalyst sequence to watch is whether AI-driven capex remains concentrated in a few hyperscalers or broadens into enterprise/sovereign demand; the former is supportive but brittle, the latter would extend the cycle by several quarters. If memory pricing decelerates before tool lead times roll over, Lam can re-rate lower even with fundamentals still healthy.

Consensus may be too comfortable treating this as a linear beneficiary of AI spend. The more interesting debate is whether Lam’s moat translates into sustained share gains across the full memory stack, not just a temporary cyclical uplift; if yes, the stock deserves a premium to prior cycle peaks, but if not, the current enthusiasm may already discount the first 12 months of upside. In other words, the opportunity is real, but the best risk/reward is likely in buying on any post-earnings digestion rather than chasing strength outright.

Key Decisions for Investors

• Long LRCX on pullbacks over the next 1-3 weeks; target a 15-20% upside over 3-6 months if memory capex breadth improves, with a stop if hyperscaler capex guidance rolls over or memory pricing starts to weaken sequentially.
• Pair trade: long LRCX / short a more logic-levered semi-capex name over 1-2 quarters to express the view that memory intensity outperforms broader WFE spend; this should work if AI capex remains concentrated in storage and memory bandwidth rather than only leading-edge compute.
• Buy LRCX call spreads 3-6 months out to participate in a rerating while capping premium outlay; best risk/reward if implied vol is elevated into the next earnings cycle and the market is overpricing near-term digestion risk.
• Add to position only after any selloff tied to inventory or China headlines, not on momentum spikes; the setup favors entering when sentiment cools but service-revenue visibility remains intact.
• Use a trailing stop rather than a fixed profit target if the stock gaps higher on guidance, because the cycle can extend for multiple quarters but reversals tend to be abrupt once memory lead times peak.